Animal models of soft-tissue sarcoma.

Area of Science:

• Oncology
• Translational Research
• Animal Models

Background:

• Soft-tissue sarcomas (STSs) are rare and heterogeneous mesenchymal tumors with over 75 recognized subtypes.
• The rarity and diversity of patient samples present significant challenges for clinical research into sarcoma biology and treatment.

Purpose of the Study:

• To highlight the utility of animal models in advancing the understanding and treatment of soft-tissue sarcomas.
• To review the role of established animal models in investigating sarcoma pathogenesis and evaluating therapeutic strategies.

Main Methods:

• Review of recent advancements in genetically engineered mouse and zebrafish models for soft-tissue sarcoma research.
• Analysis of how these models are utilized to study oncogenes, signaling pathways, and cellular changes in STS development.
• Examination of the application of these models as preclinical platforms for drug and treatment regimen evaluation.

Main Results:

• Successful development of genetically engineered mouse and zebrafish models for studying soft-tissue sarcomas.
• Demonstrated utility of these models in elucidating the molecular mechanisms underlying STS development.
• Established these models as valuable preclinical tools for testing novel therapeutic interventions.

Conclusions:

• Animal models are indispensable for understanding soft-tissue sarcoma susceptibility and pathogenesis.
• These models serve as effective surrogates for preclinical testing of potential therapeutic strategies, accelerating the development of new treatments for STS.